Lilly in the news

Lilly Cuts Earnings Guidance on Research Charges, Shares Fall.com

Read on: Bloomberg

New Eli Lilly-made GLP-1 pill could work as well as its injectable Mounjaro, Zepbound

Read on: The Washington Times

Lilly Soars After Pill Shows Its as Good as Ozempic.com

Read on: Bloomberg

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Read on: Quartz

Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound

Read on: CNBC News

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

Read on: CNBC News

Lilly asks to join lawsuit over compounded versions of its weight-loss drugs

Read on: CNBC News

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps

Read on: CNBC News

RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundup

Read on: Quartz

Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

Read on: CNBC News

Scoop: Trump, RFK Jr. dine with Pfizer and Lilly execs

Read on: Axios

How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS

Read on: CNBC News

Lilly Sues U.S. to Change Hospital Drug Discount Payments

Read on: The Wall Street Journal

Medicaid dominates coverage of Novo, Lilly weight-loss drugs

Read on: Fast Company

FDA will reconsider decision barring copycat versions of Lilly weight loss drug

Read on: The Hill

U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug

Read on: CNBC News

Lilly Fires Warning Shot at Copycat Drug Makers After Shortage

Read on: Bloomberg

Lilly Wants Records of People Who Took Weight-Loss Knockoffs

Read on: Bloomberg

Lilly slashes prices on lowest doses of weight loss drug Zepbound

Read on: NBC News